PwC MoneyTree is the go-to source for Venture Capital firms and high growth startups.
In Q3 2017, investors deployed $19 billion to US VC-backed companies across 1,207 deals, nearly the same exact total as last quarter. Funding activity was driven by another strong quarter of mega-rounds of $100 million or more, as Q3 2017’s total reached 26. The deal total was just one short of the tally in Q2 2017, just above the 8-quarter low seen in Q4 2016.
PwC and CB Insights' Healthcare MoneyTree™ report brings you a quarterly publication based on US venture capital funding for healthcare related industries. Each issue is broken out by five key sections: US healthcare trends, US healthcare industries, US healthcare places, US healthcare movers and shakers, and Global healthcare trends.
The PwC MoneyTree website is home to the PwC/CB Insights quarterly MoneyTree Report. It contains historical trend data beginning with 1995, updates on the Venture Capital and high-growth startups ecosystem, and relevant insights from PwC’s emerging company services and venture capital tax, audit, and advisory experts. The PwC/CB Insights MoneyTree Report is the definitive source of information on venture capital investments in emerging companies. This study is a staple of the financial community, entrepreneurs, government policymakers and the business press worldwide.
“With 40% of value coming from mega-deals, Q3 2017 saw the largest quarter for deal value in two years. Three of the quarter’s five largest occurred outside of California, further demonstrating the overall health of the venture capital ecosystem across the U.S.”
This publication identifies and assesses activity and trends in both the US equity and US debt capital markets in 2016.
What challenges are Venture Capitals facing today?
What challenges are high growth startups facing today?
Read the current quarter MoneyTree press release
Find out the results of the latest Technology Deals Insights report
Check out the latest analysis on the PwC MoneyTree blog
Check out the latest insights on Technology deals
Partner, US Pharmaceuticals and Life Sciences
Tel: +1 (408) 817 5029